Who We Are

Working together to advance research
and improve patient care and outcomes.

Who We Are

About the Registry

The GO2 Foundation for Lung Cancer - formerly known as the Bonnie J. Addario Lung Cancer Foundation (ALCF) founded the Lung Cancer Registry in 2016 and, by joining forces with the American Lung Association and the International Association for the Study of Lung Cancer (IASLC), expanded this effort to advance research for the world's deadliest cancer. The Lung Cancer Registry is a community for people with all forms of lung cancer. Powered by data from patients and caregivers, this platform gives those most affected by lung cancer a voice.

Registered patients, caregivers, clinicians, and researchers can access the de-identified information. Researchers use the information patients and caregivers provide as a research tool to help discover new findings. By sharing their cancer journeys and participating in research surveys, patients and caregivers help improve patients’ lives by supporting research into better treatments, care, and outcomes.

Messages From Our Sponsoring Members

Nearly a quarter million Americans will be diagnosed with lung cancer this year. Gathering information from patients and passing that knowledge on to other lung cancer patients accurately and quickly is helping patients live longer, which is our goal.– Bonnie J. Addario, Co-Founder and Chair of the Board of Directors of the GO2 Foundation for Lung Cancer

Too many Americans face lung cancer, and we simply must do more to save lives. To ultimately defeat this disease, we embrace innovative approaches like the Lung Cancer Registry, which will allow researchers to directly gain knowledge from patients to better inform treatment, and save lives.– Harold P. Wimmer, National President and CEO of the American Lung Association

Information saves lives. The IASLC is proud to partner on this truly collaborative effort, sharing data and perspective among doctors and care teams, patients, caregivers, Registry partners and all involved in conquering thoracic cancers.– Dave Mesko. International Association for the Study of Lung Cancer CEO